Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Pfizer
Company Monitoring Page for Pfizer
latest headlines for company on cafepharma
Pfizer Confirms to Cut Workforce by 2%
TheStreet.com
Thu, 10/18/18 - 11:31 am
Tags:
Pfizer
,
layoffs
,
reorganization
Can Pfizer's new breast cancer drug Talzenna really make a dent in the PARP field?
Fierce Pharma
Thu, 10/18/18 - 12:15 am
Tags:
Pfizer
,
breast cancer
,
PARP inhibitors
,
Talzenna
2 Big Pharmas Pleased With J&J's Third-Quarter Earnings Report
Motley Fool
Thu, 10/18/18 - 12:10 am
Tags:
JNJ
,
earnings
,
Pfizer
,
Merck
Drug giant Pfizer offers early retirement ahead of layoffs in memo to employees
CNBC
Wed, 10/17/18 - 02:32 pm
Tags:
Pfizer
,
layoffs
,
retirement
Are all new sales created equal?
EP Vantage
Wed, 10/17/18 - 10:28 am
Tags:
GSK
,
Pfizer
,
Novartis
Trump wants drug commercials to include prices. These five companies have the most at stake
Stat
Wed, 10/17/18 - 09:09 am
Tags:
Donald Trump
,
drug ads
,
drug pricing
,
Pfizer
,
AbbVie
,
Eli Lilly
,
Amgen
,
Allergan
FDA approves Pfizer's drug for advanced breast cancer
Reuters
Tue, 10/16/18 - 08:40 pm
Tags:
FDA
,
Pfizer
,
PARP inhibitors
,
talazoparib
,
breast cancer
,
BRCA-mutant breast cancer
Pharma Failures Actually Advance Medicine
Forbes
Tue, 10/16/18 - 11:49 am
Tags:
FDA
,
R&D
,
drug development
,
Pfizer
,
Torcetrapib
UnitedHealthcare gives Remicade biosims a leg up with changes to Medicare plans
Fierce Pharma
Mon, 10/15/18 - 11:30 pm
Tags:
CMS
,
UnitedHealthcare
,
Medicare
,
JNJ
,
Remicade
,
biosimilars
,
Pfizer
,
Merck
7 drugmakers to watch during Q3 earnings
Biopharma Dive
Mon, 10/15/18 - 12:31 pm
Tags:
earnings
,
Novartis
,
Gilead Sciences
,
Amgen
,
Pfizer
,
GSK
,
AbbVie
,
Regeneron
Pharma TV buys so far top last year's $1B spend; AbbVie, Pfizer lead September
Fierce Pharma
Mon, 10/15/18 - 12:12 pm
Tags:
drug ads
,
television ads
,
AbbVie
,
Pfizer
3 Big Pharma Stocks Racing Along the Road to China
Motley Fool
Fri, 10/12/18 - 10:20 am
Tags:
China
,
cancer
,
Pfizer
,
AstraZeneca
,
JNJ
Pfizer To Pay $700,000 To Settle 'deceptive Advertising' Charges
Market Insider
Thu, 10/11/18 - 11:11 pm
Tags:
Pfizer
,
advertising
,
copay coupons
Pfizer, J&J, Amgen and Roche Start a Bare-Knuckle Brawl Over Biosimilars
BioSpace
Thu, 10/11/18 - 09:38 am
Tags:
Pfizer
,
Amgen
,
Roche
,
FDA
,
social media
,
biosimilars
Lilly, Merck and Pfizer lead pharma's share price gains through 9 months: report
Fierce Pharma
Wed, 10/10/18 - 12:34 pm
Tags:
drug pricing
,
Eli Lilly
,
Merck
,
Pfizer
Myriad and Pfizer Sign Deal to Commercialize Companion Diagnostic
CP Wire
Tue, 10/9/18 - 10:52 am
Tags:
Myriad Genetics
,
Pfizer
,
talazoparib
,
BRACAnalysis CDx
Pfizer shakes up the top team that will now lead the pharma giant under Albert Bourla
Endpoints
Tue, 10/9/18 - 10:50 am
Tags:
Pfizer
,
executives
,
Albert Bourla
,
Ian Read
Tue, 10/9/18 - 09:44 am
Tags:
Myriad Genetics
,
Pfizer
,
talazoparib
,
BRACAnalysis CDx
Moody's picks 5 early winners in biosimilar market
Biopharma Dive
Fri, 10/5/18 - 09:01 pm
Tags:
biosimilars
,
Pfizer
,
Biogen
,
Novartis
,
Amgen
,
Mylan Labs
Mylan secretly maneuvered to suppress evidence in EpiPen suit, plaintiffs say
Fierce Pharma
Wed, 10/3/18 - 06:48 pm
Tags:
Mylan Labs
,
Pfizer
,
EpiPens
Pages
« first
‹ previous
…
91
92
93
94
95
96
97
98
99
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.